News & Info
CancerLinQ®: Enhance Quality. Advance Discovery
O'Neal Comprehensive Cancer Center at UAB: CancerLinQ Discovery
mCODE: Minimal Common Oncology Data Elements
New Mexico Cancer Center: CancerLinQ Quality Platform
CancerLinQ Practice Testimonial: New Mexico Cancer Center
CancerLinQ Practice Testimonial: Avera Cancer Institute
CancerLinQ Practice Testimonial: New England Cancer Specialists
CancerLinQ Vanguard Practices
Press Releases
Dr. Sean Khozin, Oncologist and Data Scientist, Named New CEO of ASCO’s CancerLinQ
ASCO
A board-certified oncologist, physician-scientist, and data science expert, Dr. Khozin is a proven leader and visionary in deploying cutting-edge…
CancerLinQ Data Reveals Black and Hispanic Patients With Cancer Face Greater Risk of COVID-19 Infection
ASCO
Black and Hispanic patients with cancer were more likely to be infected with COVID-19 than white patients, based on the findings of a study of more…
ASCO’s CancerLinQ Launches the SmartLinQ™ QOPI® Certification Pathway, an Automated Solution for Quality Reporting for QOPI Certified Practices
ASCO
ASCO’s CancerLinQ® today launched the SmartLinQ™ QOPI® Certification Pathway, an application that empowers oncology practices to automate quality…
New CancerLinQ Discovery® Research Platform Offers Researchers Easy Access to Real-World Cancer Data
ASCO
ASCO’s CancerLinQ® announced today that it has launched a new platform for CancerLinQ Discovery®, its de-identified real-world cancer data product…
Status Update on Data Required to Build a Learning Health System
Journal of Clinical Oncology
Wide adoption of electronic health records (EHRs) has raised the expectation that data obtained during routine clinical care, termed “real-world”…
First Cancer Center in U.S. History Signs on to Participate in CancerLinQ Platform
ASCO
Roswell Park Comprehensive Cancer Center of Buffalo, N.Y., has just signed an agreement to use the CancerLinQ® platform.
Articles
Next-Generation Sequencing and the Clinical Oncology Workflow: Data Challenges, Proposed Solutions, and a Call to Action
JCO Precision Oncology
Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and…
CancerLinQ: Cutting the Gordian Knot of Interoperability
Journal of Oncology Practice
The 2017 ASCO Oncology Practice Census identified that practices face a major source of pressure in their need to electronically integrate patient…
Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ
Future Medicine
In recent years, the field of oncology has been characterized by remarkable diagnostic and therapeutic promise accompanied by astonishing complexity…
Perspectives on the Implementation of an Ethical Rapid Learning Health System
Journal of Oncology Practice
In 2015, ASCO launched CancerLinQ (CLQ) in response to the Institute of Medicine’s call to medical societies to develop and implement rapid learning…
Qualitative Study of Oncologists' Views on the CancerLinQ® Rapid Learning System
Journal of Oncology Practice
ASCO is actively developing CancerLinQ (CLQ), a rapid learning system for oncology care. The purpose of this study was to explore providers’ opinions…
Patient Perspectives on the Ethical Implementation of a Rapid Learning System for Oncology Care
Journal of Oncology Practice
A rapid learning system (RLS) of health care harnesses data generated from routine patient care to create a virtuous cycle of data collection and…
